dilp79

dilp79 Updated 

pay attention to volume on 23rd july and short it now. Target $70

dilp79 Updated 

even without vaccine considiration, GSK is good business with price at multiyear bottom zone. Started in september trials on vaccine, later in oct progress would be more clear, still there are no factors for price go lower. Put tight stop loss under 37. Next support level is 35, so if 37 would be broken and retested - take short position.

dilp79 Updated 

hype is over, need to back closer to fundamentals based on forward p/e

dilp79 Updated 

Last price action is dodji and price is between two trends. It would move in one or another direction with good impulse. Buy options - straddle / strangle construction. i would use ATR to define ranges.

dilp79 Updated 

would move to liquidity zone at 15

dilp79 Updated 

also need to close gap in mid term.

dilp79 Updated 

price at multimonth lows, bouncing back to growth

dilp79 Updated 

Nvidia on hype with today's news to release cool new cloud AI, DPU, dev kit.